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Infection with the human immunodeficiency virus (HIV) (1-3) often results
in clinically apparent disease only after intervals of months to years. During this
latent or subclinical phase of infection, HIV continues to replicate at low levels
despite an often vigorous but apparently ineffective host immune response (4) .
Mechanisms that contribute to this persistent, low-level infection, as well as the
cellular reservoirs for HIV during this latent period, are not fully understood .
Several lines of evidence now document cells of the monocyte/macrophage lin-
eage as major targets for persistent HIV in vivo (5-12) . In this respect, HIV is
similar to several ruminant lentiviruses that show strong tropism for macro-
phages during both viral latency and active replication (13-15) . If macrophages
also serve as a viral reservoir during HIV infection, then analysis of these
infected cells may explain mechanisms of viral persistence, dissemination, and
ultimately clinical disease .
In this report, we describe an in vitro system that allows replication of HIV
in blood-derived monocyte/macrophages from normal donors . Purified mono-
cytes were cultured for intervals > 3 mo in medium supplemented with human
rCSF-1 (16, 17) . These cultures provided susceptible target cells for HIV infec-
tion . Cocultivation of PBMC from patients with AIDS or AIDS-related complex
(ARC)' and rCSF-1-treated monocytes from normal donors resulted in isolation
of progeny HIV virions in the majority of patients tested .
Materials and Methods
Isolation and Culture ofPeripheral Blood Monocytes.
￿
Populations of monocytes were iso-
lated by countercurrent centrifugal elutriation of mononuclear leukocyte-rich fractions
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1 Abbreviations used in this paper:
￿
ARC, AIDS-related complex; UA, uranyl acetate.
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of blood cells from normal donors undergoing leukopheresis (18). Cell suspensions were
> 96% monocytes by the criteria of cell morphology on Wright-stained cytosmears (96
± 2%, mean ± SEM for six determinations), by granular peroxidase (95 ± 3%), and by
nonspecific esterase (98 ± 2%). Elutriated monocytes were cultured as adherent cell
monolayers in DMEM (formula 780176AJ, Gibco, Grand Island, NY) supplemented with
10% freshly obtained, heat-inactivated, normal human serum, 50 Ag/ml gentamicin, and
1,000 U/ml rCSF-1 (Cetus Corp., Emeryville, CA) (16, 17).
Isolation and Culture of PHA-stimulated PBMC (Lymphoblasts).
￿
PBMC isolated from
whole blood by Ficoll-diatrizoate density grandient centrifugation were cryopreserved
and stored in liquid nitrogen. 3 d before use for virus isolation, cells were quickly thawed
and stimulated with the T cell mitogen, PHA (1-3).
Virus Isolation by Monocyte or Lymphoblast Cocultivation.
￿
Monocytes treated with rCSF-
1 and maintained in culture for at least 7 d were used for cocultivation experiments with
freshly isolated PBMC from seropositive HIV-infected individuals. Aliquots of Ficoll-dia-
trizoate-separated PBMC (5 X 105 cells/culture well) were admixed with equal numbers
of adherent rCSF-1-treated monocytes in 16-mm-diameter culture wells (Cluster24;
Costar Data Packaging Corp., Cambridge, MA) or with suspensions of PHA-stimulated
lymphoblasts (1-3). Fluids from all cultures were sampled daily and assayed by ELISA
(Cellular Products, Inc., Buffalo, NY) for presence of HIV-specific antigens and/or
reverse transcriptase activity for at least 40 d. Reverse transcriptase assays were per-
formed with [ 2P] deoxythymidinetriphosphate in a protocol modified from that
described by Goff et al. (19, 20).
ImmunofuorescenceAnalysis by Flow Cytometry.
￿
Uninfected (10 d) and HIV-infected (40
d) rCSF-1-treated monocytes were cultured and recovered from Teflon-coated tissue cul-
ture flasks (Cole-Parmer Instrument Co., Chicago, IL). For all experiments, 106 cells
were incubated with 1 :100 dilution of mAb anti-HLe-1 (CD45, Becton Dickinson & Co.,
Mountain View, CA), Leu-M3 (CD14, Becton Dickinson & Co.) B4 (CD 19), J5 (CD10),
T4 (CD4), T6 (CD 1), T8 (CD8), and TI 1 (CD2 ; all from Coulter Immunology, Hialeah,
FL) or 1 :50 dilution of pooled AIDS patients' sera from HIV-1- and HIV-2-infected
individuals. After the initial antibody incubation, cells were washed after centrifugation
and resuspended in 1 :100 dilution of fluorescein-conjugated horse anti-mouse or goat
anti-human IgG. Immunofluorescence of individual cells previously fixed in 1 % para-
formaldehyde were analyzed by FACS flow cytometry.
Detection ofHIV-specific Polypeptides by Radioimmunoprecipitation.
￿
Adherent monolayers
of rCSF-1-treated monocytes chronically infected (30 d) with HIV-1 (patient Ada, second
passage) were washed twice and cultured in methionine-free DMEM with 2% dialyzed
FCS for 2 h. Cells were labeled with ["S]methionine (100 ,ACi/ml) for 8 h. Radiolabeled
cell lysates were mixed with AIDS patients' sera for 12 h at 4°C and the immune com-
plexes were recovered on protein A-Sepharose (Pharmacia Fine Chemicals, Piscataway,
NJ) . Eluted immune complexes were subjected to SDS-PAGE as described (21).
Detection of HIV-specific DNA by Southern Blot Hybridization.
￿
DNA was prepared from
HIV-infected (patient 120 isolate, second passage at 30 d) rCSF-l-treated monocytes and
analyzed for presence of virus-related sequences by Southern blot hybridization of Hind
III-digested cellular DNA with the pBenn6 gag-pol-env probe (22).
In Situ Hybridization with HIVRNA Probes.
￿
Subgenomic viral DNA fragments present
in pBI (23), pBenn6 (22), pBl l (23), and a recombinant plasmid (pRG-B) that contains
a 1 .35-kb Hind III fragment mapping between 8.25 and 9.6 kb on the proviral DNA
were subcloned into SP6/T7 vectors (Promega Biotec, Madison, WI), and the pooled
DNAs were transcribed using 3'S-UTP (Amersham Corp., Arlington Heights, IL). The
labeled RNAs were incubated with 40 mM NaHCO3/60 AM Na2COs, pH 10.2, before
hybridization to facilitate their entry into cells. Cytosmears of cultured monocytes were
prepared onto polylysine-coated glass slides, fixed in periodate/lysine paraformaldehyde/
glutaraldehyde, and pretreated with proteinase K, triethanolamine, and HCl. Specimens
were prehybridized in 10 mM Tris (pH 7.4), 2X SSC (1X SSC is 0.15 M NaCl, 0.015 M
sodium citrate, pH 7.4), 1X Denhardt's solution (0.02% polyvinylpyrrolidone, 0 .02%
Ficoll, 0.02% BSA), and 200 Ag/ml yeast tRNA at 45°C for 2 h, and hybridized in this1430
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solution with 10% dextran sulfate, 5 uM dithiolthreitol and 106 cpm 35S-labeled HIV
RNA. Slides were serially washed in solutions with RNase to reduce binding of nonhy-
bridized probe. Autoradiography was performed in absolute darkness (6).
To control for the specificity of in situ hybridization, probes synthesized in the sense
orientation (same polarity as viral mRNA) were incubated with replicate cell prepara-
tions. Additionally, uninfected cells were hybridized with antisense probes (i.e., comple-
mentary to viral mRNA).
EM Examination of Monocyte Cultures.
￿
HIV-infected or uninfected rCSF-1-treated
monocytes were grown on plastic dishes or recovered from Teflon flasks. Cells were har-
vested at 10 and 40 d, washed in PBS, and immediately fixed with 2% glutaraldehyde in
0.1 M cacodylate buffer (pH 7.4) overnight at 4°C. Fixed cells were gently transferred
to 1.5-ml microfuge tubes using a large-bore Pasteur pipette and were pelleted after
centrifugation. The cell pellet was further processed through 1% Os04, blocked in uranyl
acetate (UA), stained for 1 h in saturated UA in 50% ethanol, dehydrated in graded
ethanol and propylene oxide, and embedded in epon. Thin sections were stained with
UA and lead citrate and examined in a Zeiss EM IOAR EM operating at 60 kV.
Results
Culture of rCSF-1-treated Blood Monocytes. Relatively pure populations of
monocytes were obtained by countercurrent centrifugal elutriation of mononu-
clear leukocyte-rich fractions of blood cells from normal donors undergoing leu-
kopheresis (18) . Such cell suspensions were > 96% monocytes by criteria of cell
morphology on Wright-stained cytosmears, by granular peroxidase, and by non-
specific esterase. Purified monocytes were cultured in medium supplemented
with 1,000 U/ml rCSF-1 . After 5-7 d of culture, clusters of rounded, loosely
adherent, proliferating monocytes were observed scattered throughout a mono-
layer of adherent fusiform cells (Fig. 1) . Low levels of cell division were con-
firmed by [3H]thymidine incorporation and the presence of mitotic figures in
1-5% of the cells. In coincident experiments, monocytes in aliquots of the same
cell suspension cultured without rCSF-1 for 7 d appeared spread, vacuolated,
and granular. No proliferating cell clusters were observed and the absolute cell
number was < 20% of the initial inoculum. In contrast, the number of cells in
rCSF-1-treated monocyte cultures at 7-10 d ranged from 90-150% of the initial
inoculum. EM examination of 100 individual cells after 10 d in culture showed
that all cells had ultrastructural characteristics typical of macrophages: irregular
outlines, abundant lysosomes, prominent perinuclear Golgi, and eccentric
nuclei. Cell surface antigens in these monocyte cultures were also characterized
at 10 d by mAbs and analyzed by FACS flow cytometry. More than 98% of cells
were positive for HLe-1 (CD 45) and Leu-M3 (CD 14); binding of anti-B4 (CD
19), J5 (CD10), T4 (CD 4), T6 (CD1), T8 (CD 8) or T11 (CD2) were each below
levels of detection. Thus by antigenic, histochemical, morphologic, and ultra-
structural analysis, virtually all of the cells in these 10-d suspensions were iden-
tified as monocytes/macrophages.
Isolation of HIV from PBMC of Seropositive Individuals onto rCSF-1-treated
Monocytes of Normal Donors. Repeated attempts to propagate established labo-
ratory strains of HIV in monocytes were uniformly negative over a time interval
of >6 mo (data not shown). These attempts were repeated with the rCSF-1-
treated monocyte culture technique described above. Monocytes treated with
rCSF-1 for at least 7-10 d were used for cocultivation experiments with freshlyGENDELMAN ET AL .
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FIGURE 1. Light microscopic characteristics of blood-derived monocytes cultured with
rCSF-1 for (A) 10 and (B) 40 d . Note heterogeneous cell populations : small cells with dense
nuclear chromatinand moderate cytoplasm; larger cells with extensive and diffuse cytoplasm
and eccentric nucleus ; and individual fusiform cells with fibroblast-like morphology ; islands
of aggregated and proliferating cells . Original magnification, X 80 .
isolated PBMC from seropositive HIV-infected individuals (Table I) . Aliquots of
PBMC from each of five patients were cocultivated with rCSF-1-treated adher-
ent monocyte monolayers and suspensions of PHA-stimulated PBMC (lympho-
blasts) from normal donors. Culture fluids were sampled daily and assayed for
HIV-specific antigens and/or reverse transcriptase . Isolation of HIV was suc-1432 ISOLATION OF HUMAN IMMUNODEFICIENCY VIRUS
TABLE I
Virus Isolationfrom PBMC ofHIV-infected Patients by Monocyte or Lymphoblast
Cocultivation
Patient
HIV reverse transcriptase activity in culture
fluids of patient PBMC cocultivated with:
Aliquots of Ficoll-diatrizoate-separated PBMC were admixed with equal numbers of
adherent rCSF-l-treated monocytesor with PHA-stimulated lymphoblasts. Fluids from
allcultures were sampled daily andassayed for HIV-specific reverse transcriptase activ-
ity for 40 d. Reversetranscriptaselevels representpeak activity. Day at which virus was
first detected in monocyte cultures is shown in parentheses.
cessful in all five patients by cocultivation with rCSF-1-treated monocytes or
lymphoblasts. Antigen-capture assays confirmed isolation of HIV in each
instance. One patient had a lymphoblast isolate and not a monocyte isolate;
another patient had a monocyte but not a lymphoblast isolate. With three
patients, both monocyte and lymphoblast isolates were obtained; the peak
reverse transcriptase activity and HIV viral antigen level in lymphoblast cultures
were 10-fold higher than those in monocyte cultures.
Progeny virions released in supernatant fluids of infected monocyte and lym-
phoblast cultures were used to serially infect other rCSF-1-treated monocyte
and lymphoblast cultures . In all cases, viral inoculum was adjusted to 5 X 10'
cpm/ml reverse transcriptase activity in 0.5-ml filtered (0 .22-Am filter units; Mil-
lipore Continental Water Systems, Bedford, MA) culture fluid. HIV initially iso-
lated on monocyte or lymphoblast cultures serially infected normal homologous
cells with all isolates tested. Serial passage of HIV (patient 120 isolate, see Table
1) initially isolated on monocytes into other rCSF-1-treated monocyte cultures
resulted in a progressive increase in viral titer (Fig. 2) . In the second passage,
distinctive changes in cell morphology and some cell death were noted in
monocyte cultures 8-14 d after HIV infection. Appearance of cell debris and
changes in cell morphology in the rCSF-1-treated monocyte monolayer were
coincident with peaks of reverse transcriptase activity in culture fluids. Multi-
nucleated giant cells with > 20 nuclei/cell were noted in 10-20% of monocytes.
Replicate rCSF-1-treated monocytes cultured alone as adherent monolayers or
cocultivated with PBMC from HIV seronegative control donors did not show
these changes . HIV-specific reverse transcriptase activity was detected in culture
CD4+ T
cells/mms
PHA-induced
lymphoblasts
cpm/ml X 10-3
rCSF-1-treated
monocytes
Ada: 36-yr-old male homosexual 252 1,000 70 (35 d)
with Kaposi's sarcomafor 4 yr
Ree: 44-yr-oldmale homosexual 208 900 100 (22 d)
with Kaposi's sarcomafor I yr
120: 27-yr-oldmale i.v. drug abuser 360 200 40 (25 d)
with ARC for 1 yr
121: 32-yr-oldmale i.v. drug abuser 582 500 None
with ARC for 9 mo
167: 24-yr-oldmale homosexual 433 None 160 (36 d)
with ARCfor 1 yrX
_ff
if
120
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FIGURE 2.
￿
Serial passageof virus isolated
from PBMC of patient 120 into rCSF-1-
treated monocytes. Aliquots of Ficoll-
Ih, primary
￿
diatrizoate-separated PBMC suspensions
isolation
￿
from patient 120 were admixed with equal
numbers of adherent rCSF-1-treated I ;
I . , {primry} monocytesa isolation . Culture
fluids were sampled daily and assayed for
HIV-specific reverse transcriptase activity.
For each subsequent passage into rCSF-1-
Control
￿
treated monocytes, viral inoculum was
adjusted to 5 X 10' cpm/mi reverse tran-
20
￿
30
￿
4
￿
scriptase activity in filtered culture fluid
Oat's MW Nation
￿
MZ in]).
fluids through 40 d. Significantly, at these later t 0__
in the HIV-infected monocyte monolayer appeared morphologically normal.
After three passages on homologous cells, monocyte and lymphoblast HIV
isolates were each added to heterologous cells; in each instance, sustained, pro-
ductive viral infection was not demonstrated. Similarly, several different strains
of HIV-1, such as lymphadenopathy associated virus or LAV that were each
maintained for long intervals in normal lymphoblasts or continuous T cell lines,
all failed to infect rCSF-1-treated monocyte/macrophage cultures even at viral
inocula 20-fold higher than that needed to infect lymphoblasts. One macro-
phage-tropic HIV patient isolate (Ado) infected PHA-stimulated lymphoblasts
after five serial passages in rCSF-1-treated monocytes. In marked contrast to the
preceding observations, a well-characterized HIV-2 isolate (ROD) that had been
serially passaged in lymphoblasts and continuous T cell lines (24) infected rCSF-
1-treated monocytes; peak reverse transcriptase activity, 2 X 105 cpm/ml, was
detected 8 d after infection.
Characterization of the Macrophage Variant HIV.
￿
HIV-specific proviral
was detected by Southern blot hybridization of Hind III-digested DNA pre-
pared from HIV-infected (patient 120 isolate, second passage at 30 d) rCSF-1-
treated monocytes (Fig. 3 A). Two cleavage products (4.5 and 2.0 kb) reacted
with the pBenn6 DNA probe. Radioimmunoprecipitation of HIV-associated
proteins from [3lSjmethionine-labeled, HIV-infected rCSF-1-treated monocytes
(patient Ada isolate, second passage at 30 d) showed detectable levels of synthe-
sis for envelope Q 160 and gp 12Q and gag (p55 and p39) proteins (Fig. 3 B).
Levels of HIV gene synthesis in chronically infected monocyte cultures were fur-
ed by assay of virus-specific RNA and proteins. In situ hybridizati1434
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FIGURE 3 . (A) Detection of HIV-
specific DNA by Southern blot
hybridization . DNA was prepared
from HIV-infected (patient 120 iso-
late, second passage at 30 d) rCSF-
1-treated monocytes and analyzed
for presence of virus-related se-
quences by Southern blot hybridiza-
tion of Hind III-digested DNA with
the pBenn6 probe . (B) Detection of
HIV-specific polypeptides by
radioimmunoprecipitation of cell
lysates from adherent monolayers of
rCSF-1-treated monocytes chroni-
cally infected (30 d) with HIV-1
(patient Ada, second passage) . Su-
pernatant fluids from [s5S]methio-
nine-labeled cell lysates were mixed
with pooled AIDS patients' sera and
the immune complexes were sub-
jected to SDS-PAGE . Immunopre-
cipitate bands representing envelope
(gp 160 and gp 120) and gag (p55
and p39) proteins are clearly identi-
fied in lane 2 . Molecular weight
markers were applied to lane 1 .
of infected monocytes with HIV RNA probes and analysis of the hematoxylin-
stained cytosmears by autoradiography documented a large subpopulation of
cells (60-90%) that expressed viral RNA (Fig . 4) . Similarly, analysis of chroni-
cally infected monocyte populations (patient 120 isolate, second passage at 40
d) by binding of antibodies in AIDS patients' sera as quantified by FACS flow
cytometry also documented a large subpopulation of cells (60-88%) that
expressed viral protein. These results, however, stand in sharp contrast to the
relatively low levels of reverse transcriptase activity or HIV antigens found in
culture fluids . Independent estimates of viral RNA and protein produced by
HIV-infected monocytes suggested a massive infection, yet the amount of virus
released into culture fluids was exceedingly small .
EM analysis of HIV-infected monocyte cultures resolved this apparent para-
dox . Monocytes chronically infected (40 d) with HIV-1 (patient 120, second pas-
sage) initially isolated in rCSF-I-treated monocyte cultures were fixed in 2% glu-
taraldehyde and were prepared for transmission EM . Virus particles were
identified in ^-15% of macrophages examined . Virions typical of lentiviruses
(25) were numerous (100-300 particles/cell) and uniformly localized to intra-
cytoplasmic vacuoles (Fig. 5) . Viral particle size and nucleoid appearance was
pleomorphic . Virons were commonly seen budding into cytoplasmic vacuoles
but only rare viral particles were observed associated with the plasma mem-
brane . Similar findings were evident in rCSF-1-treated monocytes chronicallyGENDELMAN ET AL .
￿
1435
FIGURE 4 .
￿
In situ hybridization of HIV-infected (patient Ada isolate, third passage) rCSF-
1-treated monocytes . Silver grains (HIV-specific RNA) overlie infected cells.
infected (40 d) with the HIV-2 (ROD) isolate (Fig. 6) . With HIV-1, plasma mem-
brane budding was observed at low levels during the acute phase of infection
(10-14 d), but again intracellular accumulation of virus particles within cyto-
plasmic vacuoles was the predominant finding .
The pattern of HIV replication in monocytes and T cells is thus very different .
HIV-infected monocytes accumulate large numbers of budded virus in intracy-
toplasmic vacuoles during both acute and chronic infections ; release of virus
from the plasma membrane is infrequent and at relatively low levels (0-10 par-
ticles/cell section) . This pattern of viral replication in rCSF-1-treated monocytes
was observed with three different patient isolates of HIV (patients Ada and
120), and HIV-2 (ROD) ; viral particles were identified in -15% of monocytes
examined at 4-6 wk. In contrast, the HIV-infected T cell releases large numbers
of viral particles from the plasma membrane (often hundreds of virions/cell sec-
tion) ; the number of virions that reside in cytoplasmic vacuoles in these cells is
exceedingly small . The concept that HIV virions produced in macrophages accu-
mulate intracellularly and are only inefficiently transported out of the cell was
confirmed by comparison of fluid-phase reverse transcriptase levels in monocyte
cultures before and after three successive freeze-thaw cycles . The amount of
reverse transcriptase activity detected in monocyte cultures after the freeze-thaw
cycles was 10-20 times higher (9 X 105 cpm/ml) than that of control levels .
Virus released into culture fluids by freeze-thaw cycles was fully infectious for
rCSF-1-treated monocytes .1436
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FIGURE 5.
￿
(A) Transmission EM of an HIV-1-infected (patient 120 isolate, second passage)
rCSF-1-treated monocyte at 40 d of culture. Part of a relatively small eccentric nucleus,
numerous electron-dense lysosomes and an irregular surface with pinocytic vesicles are seen .
Several vacuoles with numerous viral particles are present in the central cytoplasm . The inset
shows virus budding into a vacuole (arrow) that also contains several mature virions with
dense conical nucleoids . Virus surface spikes are not apparent . Original magnification, X
6,500 (inset : X 100,000) . (B) In the same preparation, three irregular cytoplasmic vacuoles
contain many mature virions and several budding or incomplete (immature) viral particles
(arrows) . One of the budding virions (arrowhead) is enlarged in the inset . A mature virus par-
ticle is associated with the plasma membrane. Virus surface spikes are not apparent . Original
magnification, X 58,000 (inset : X 200,000) .GENDELMAN ET AL .
FIGURE 6 .
￿
(A) Transmission EM of an HIV-2 (ROD)-infected rCSF-1-treated monocyte at
40 d of culture . Irregular surface processes, pinocytic vesicles, lysosomes, and lipid vacuoles
are observed. Innumerable virus-bearing vacuoles of varying sizes fill the central cytoplasm .
One of several budding virions (arrow) covered by prominent surface spikes is enlarged in
the inset . Original magnification, X 9,400 (inset : X 200,000) . (B) In the same preparation,
one large cytoplasmic vacuole contains numerous pleomorphic mature and a cluster of three
immature virus particles (arrow) . Three small vacuoles each contain a single virion. Original
magnification, X 58,000 .
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Discussion
The preceding observations document recovery of HIV tropic for macro-
phages in a majority of patients tested. It is not clear at this point whether the
efficient isolation of HIV from patients' leukocytes into rCSF-1-treated mono-
cytes represents a change in target cell susceptibility to virus or to increased
monocyte viability in culture over extended time intervals. The role of CSF-1, a
macrophage growth factor, in HIV infection of macrophages may not be anal-
ogous to that of the T cell growth factor, IL-2, for T cells (1-3). We were able
to document only a small subpopulation of proliferating monocytes (^-1-5%)
during culture with rCSF-1, yet the percentage of HIV-infected cells detected
by in situ hybridization with HIV RNA probes or by immunofluorescence with
AIDS patients' sera exceeded 60-90%. By whatever mechanism, the findings
presented in these studies, as well as those in previous reports that document
biologically distinct HIV in brain and lung tissue, implicate variant HIV as major
participants in disease pathogenesis (5). The evidence in toto strongly suggests
the macrophage variant HIV as a major virus reservoir in early and late disease .
This concept must now be included in future drug testing and vaccine devel-
opment strategies. Moreover, the intracellular sequestration of virions in chron-
ically infected macrophages suggests new models for viral persistence and the
dissemination of disease. Indeed, accumulation of HIV within cytoplasmic vac-
uoles of macrophage-derived, multinucleated giant cells in the brain has been
recently described (26). These observations in brain tissue from AIDS patients
closely parallel the ultrastructural findings in HIV-infected macrophages
reported here. Retention of virus within macrophages is not novel for retrovi-
ruses. Other lentiviruses, such as caprine arthritis encephalitis and ovine pro-
gressive pneumonia virus also bud into and accumulate in cytoplasmic vacuoles
(27, 28). These viruses have strong tropism for blood monocytes or tissue mac-
rophages, yet viral replication is restricted and entirely dependent upon host cell
(macrophage) differentiation. The visna virus-infected macrophages act as true
"Trojan horses" (13). Infected, immature blood monocytes restrict virus repli-
cation to minimal levels. After these cells enter tissue and differentiate into
mature macrophages, however, visna virus replication increases more than sev-
eral-thousand-fold (15). Whether these same mechanisms apply to HIV-infected
human macrophages remains to be determined.
Although patient-derived HIV efficiently infects rCSF-1-treated monocyte tar-
get cells, low numbers of progeny virus are released into culture fluids. During
chronic infection, these cells appear morphologically unaffected by the infec-
tion, yet EM analysis documents large factories of virions in cytoplasmic vacu-
oles. In tissues of AIDS patients, HIV-infected mononuclear phagocytes are
detected at high frequency in the brain, lymph node, and skin (5-7, 10-12) . Do
these hidden virus factories explain how HIV escapes a competent host immune
surveillance response? It is interesting to further speculate that macrophage
variant HIV are the forms responsible for virus latency and dissemination. At
some time during disease, the macrophage variant HIV acquires T cell tropism.
Perhaps viral envelope glycoprotein undergoes successive mutations to acquire
affinity for the CD4 determinant and T cell tropism. This acquired change in
structure, and thus function, of HIV would represent a second stage of virusGENDELMAN ET AL.
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infection heralded by T4 helper cell depletion and followed by the inevitable
development of opportunistic infection and death. The full biologic conse-
quence of distinct T cell and macrophage tropic viruses in AIDS awaits further
inquiries. The system for in vitro maintenance of viable, HIV-susceptible
monocyte/macrophages described in this report can facilitate this search.
Summary
Monocytes were maintained in tissue culture for > 3 mo in media supple-
mented with rCSF-1 . These cultures provided susceptible target cells for isola-
tion and propagation of virus from PBMC of HIV-infected patients. HIV iso-
lated into monocytes readily infected other rCSF-1-treated monocytes but only
inefficiently infected PHA-stimulated lymphoblasts. Similarly, laboratory HIV
strains passaged in T cell lines or virus isolated from patients' leukocytes into
PHA-stimulated lymphoblasts inefficiently infected rCSF-1-treated monocytes.
Persistent, low-level virion production was detected in macrophage culture
fluids by reverse transcriptase activity or HIV antigen capture through 6-7 wk.
Marked changes in cell morphology with cell death, syncytia, and giant cell for-
mation were observed in monocyte cultures 2 wk after infection, but at 4-6 wk,
all cells appeared morphologically normal. However, the frequency of infected
cells in these cultures at 6 wk was 60-90% as quantified by in situ hybridization
with HIV RNA probes or by immunofluorescence with AIDS patients' sera.
Ultrastructural analysis by EM also showed a high frequency of infected cells;
virtually all HIV budded into and accumulated within cytoplasmic vacuoles and
virus particles were only infrequently associated with the plasma membrane.
Retention of virus within macrophages and the macrophage tropism of HIV
variants may explain mechanisms of both virus persistence and dissemination
during disease.
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